Dashboard
1
High Management Efficiency with a high ROE of 19.94%
2
Company has very low debt and has enough cash to service the debt requirements
3
Healthy long term growth as Net Sales has grown by an annual rate of 28.67% and Operating profit at 36.57%
4
Flat results in Dec 24
5
With ROE of 12.40%, it has a Attractive valuation with a 1.88 Price to Book Value
6
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.99%
0%
-8.99%
6 Months
-1.94%
0%
-1.94%
1 Year
0.94%
0%
0.94%
2 Years
-30.0%
0%
-30.0%
3 Years
-27.77%
0%
-27.77%
4 Years
-18.77%
0%
-18.77%
5 Years
3.36%
0%
3.36%
Beijing Tong Ren Tang Chinese Medicine Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
28.67%
EBIT Growth (5y)
36.57%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
0.35
Tax Ratio
17.26%
Dividend Payout Ratio
58.57%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
86.34%
ROE (avg)
19.94%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.88
EV to EBIT
9.91
EV to EBITDA
9.81
EV to Capital Employed
2.55
EV to Sales
4.66
PEG Ratio
1.04
Dividend Yield
0.05%
ROCE (Latest)
25.75%
ROE (Latest)
12.40%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'17 - YoY
Dec'17
Dec'16
Change(%)
Net Sales
329.80
276.00
19.49%
Operating Profit (PBDIT) excl Other Income
131.20
107.70
21.82%
Interest
0.00
0.00
Exceptional Items
0.00
-1.30
100.00%
Consolidate Net Profit
111.30
92.80
19.94%
Operating Profit Margin (Excl OI)
397.90%
390.20%
0.77%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2017 is 19.49% vs 8.19% in Dec 2016
Consolidated Net Profit
YoY Growth in quarter ended Dec 2017 is 19.94% vs -10.34% in Dec 2016
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,611.60
1,524.90
5.69%
Operating Profit (PBDIT) excl Other Income
659.60
698.70
-5.60%
Interest
6.50
6.00
8.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
529.20
590.60
-10.40%
Operating Profit Margin (Excl OI)
354.60%
404.00%
-4.94%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 5.69% vs -11.91% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -10.40% vs -14.57% in Dec 2023
About Beijing Tong Ren Tang Chinese Medicine Co., Ltd. 
Beijing Tong Ren Tang Chinese Medicine Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






